Doseology Introduces Innovative Feed That Brain® Energy Pouches in the U.S.

Doseology Launches Feed That Brain® Oral Stimulant Pouches

Kelowna, BC – On March 4, 2026, Doseology Sciences Inc. announced the launch of their innovative Feed That Brain® Energy Pouches, marking a significant step in their direct-to-consumer pilot program in the United States. These pouches, which deliver clean and controlled energy in a discreet format, reflect a modern approach to energy consumption that aligns with today’s health-conscious consumers.

The new product offers a nicotine-free and caffeine-based alternative designed to provide consistent stimulation without the drawbacks commonly associated with traditional energy drinks. Each pouch ensures portion-controlled energy delivery without any sugar, smoke, or liquids, making them ideal for consumers on the go. The availability of the Feed That Brain Energy Pouches can be found exclusively on feedthatbrain.com and Amazon.com.

This pilot aims to validate the oral pouch delivery system as a scalable platform for energy solutions, starting with non-nicotine options. Doseology plans to gather valuable insights regarding consumer adoption, usage patterns, and purchasing frequency, particularly targeting demographics that are looking for alternatives to conventional energy sources.

Larry Latowsky, the Executive Chairman of Doseology, commented, “This U.S. pilot is a disciplined and intentional move in our strategy to build a scalable oral stimulant platform. Feed That Brain showcases how controlled, non-nicotine energy delivery can satisfy evolving consumer preferences while generating necessary operational insights for sustainable growth.”

The design of the Feed That Brain Energy Pouches prioritizes ease of use, offering a clarity in energy delivery that is often lacking in liquid formats. Doseology emphasizes precision dosing and user experience in the development of their products, catering to consumers who desire a modern and portable energy solution.

The growing popularity of oral pouches coincides with a notable shift in consumer preferences toward discreet and portable delivery systems. While Feed That Brain is aimed at being a nicotine-free product, the booming nicotine pouch market highlights a transition toward acceptance of pouch formats, emphasizing their potential longevity in the functional consumer products landscape.

In addition to this launch, Doseology has also announced the granting of 140,000 restricted share units (RSUs) and 210,000 performance share units (PSUs) to one of its directors. These compensations are designed to vest over 36 months, aligning with the company’s long-term growth strategy and performance milestones.

About Doseology Sciences Inc.

Doseology Sciences Inc. is at the forefront of developing pouch-based oral stimulant and cognitive support products. The rise of oral stimulant pouches signifies a burgeoning category as consumers increasingly seek convenient and discreet alternatives to traditional modes of consumption. Compared to combustible tobacco and vaping, these pouches offer a smokeless and vapor-free option that does not involve inhalation.

From a market perspective, the oral pouch sector is witnessing significant growth on a global scale, as consumers prioritize portability and innovative delivery methods. This category has emerged as one of the most dynamic segments within modern functional consumer products, with high potential for future expansion. For more details about Doseology’s offerings, visit doseology.com or feedthatbrain.com.

On behalf of the Board of Directors,
Chris Jackson
CEO, Director
Doseology Sciences Inc.

Investor and Media Contact

For inquiries, please reach out via email at [email protected] or call 604-908-3095.

Forward-Looking Statements: This announcement contains forward-looking information subject to risks and uncertainties that may affect future outcomes. Please exercise caution and not rely solely on the predictions made herein. The company does not commit to updating these statements unless required by law.